
Bioretec Investor Relations Material
Latest events

Q2 2025
14 Aug, 2025

Q1 2025
15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bioretec
Access all reports
Bioretec Oy is a medical device manufacturer based in Finland, specializing in the development, manufacturing, and commercialization of bioresorbable orthopedic implants and implant materials. These products are designed for the treatment of bone and soft tissue injuries and are utilized in various surgical applications, including pediatrics, trauma surgery, and sports surgery. The company's Activa product line includes bioabsorbable biopolymer products. Bioretec Oy also has a subsidiary in Germany, BRI.Tech GmbH, and its products are used globally. The company is headquartered in Finland, and its shares are listed on the Nasdaq Helsinki.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BRETEC
Country
🇸🇪 Sweden